EyeGate Pharmaceuticals, Inc.
(NASDAQ : EYEG)

( )
EYEG After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
3.41%19.121.8%$142.91m
ICPTIntercept Pharmaceuticals, Inc.
-2.54%88.9118.6%$96.35m
SAGESAGE Therapeutics, Inc.
-0.30%163.978.8%$79.34m
JAZZJazz Pharmaceuticals Plc
-0.69%128.532.3%$69.92m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.88%162.456.3%$58.85m
PRGOPerrigo Co. Plc
1.91%50.146.8%$53.83m
ZGNXZogenix, Inc.
0.47%38.249.9%$47.81m
UTHRUnited Therapeutics Corporation
-1.41%102.0414.3%$44.82m
CTLTCatalent Inc
0.38%44.622.4%$39.80m
PTLAPortola Pharmaceuticals, Inc.
0.64%35.997.6%$33.80m
HZNPHorizon Pharma plc
0.64%25.306.7%$33.60m
ICLRICON Plc
1.67%136.924.1%$31.71m
ZYNEZynerba Pharmaceuticals Inc
3.20%10.338.3%$31.11m
MYOKMyoKardia, Inc.
2.85%49.052.1%$25.90m
MDCOMedicines Company
1.15%29.8021.8%$25.70m

Company Profile

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.